| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Kununya Pimolbutr | Q88929169 |
| Stefano Fedele | Q88929171 | ||
| P2093 | author name string | Stephen Porter | |
| P2860 | cites work | Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy | Q21198871 |
| Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws | Q28240354 | ||
| Romosozumab Treatment in Postmenopausal Women with Osteoporosis | Q28278665 | ||
| Bevacizumab demonstrates prolonged disease stabilization in patients with heavily pretreated metastatic renal cell carcinoma: a case series and review of the literature | Q34034222 | ||
| Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus | Q34532986 | ||
| American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update | Q34976147 | ||
| Bevacizumab-related osteonecrosis of the mandible is a self-limiting disease process. | Q35978414 | ||
| A rare case of osteonecrosis of the jaw related to imatinib | Q36360226 | ||
| [A case of osteonecrosis of the jaw during treatment by bevacizumab for sigmoid colon cancer] | Q95527011 | ||
| Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. | Q51026901 | ||
| Osteonecrosis of the jaw in a patient receiving cabozantinib. | Q51071178 | ||
| Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. | Q51522929 | ||
| Regorafenib Also Can Cause Osteonecrosis of the Jaw. | Q52985112 | ||
| Osteonecrosis of the jaw related to sunitinib. | Q54680163 | ||
| American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update | Q56565081 | ||
| Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: Report of 2 cases with clinical implications | Q57904464 | ||
| Osteonecrosis of the Jaw Related to Bevacizumab | Q60386785 | ||
| Osteonecrosis of the jaws and bevacizumab therapy: a case report | Q61775067 | ||
| Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer | Q73395687 | ||
| Bevacizumab (Avastin): An anti-angiogenic drug associated with osteonecrosis of the jaw | Q83399039 | ||
| Sunitinib related osteonecrosis of jaw: a case report | Q84323419 | ||
| Osteonecrosis after administration of intravitreous bevacizumab | Q84561165 | ||
| An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence | Q84804094 | ||
| A case report of bevacizumab-related osteonecrosis of the jaw: old problem, new culprit | Q84818261 | ||
| RE: Regorafenib Also Can Cause Osteonecrosis of the Jaw | Q87845937 | ||
| Medication-related osteonecrosis of the jaw associated with aflibercept | Q88913700 | ||
| Antiangiogenic therapy for cancer: an update | Q36563542 | ||
| Angiogenesis and its therapeutic opportunities | Q37101283 | ||
| Osteonecrosis of the jaw: who gets it, and why? | Q37307232 | ||
| Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update | Q37404224 | ||
| Osteonecrosis of the jaw associated with ziv-aflibercept | Q37525339 | ||
| Bisphosphonates and time to osteonecrosis development | Q37629434 | ||
| Osteonecrosis of the jaw associated with everolimus: A case report | Q37701817 | ||
| Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases | Q37761321 | ||
| Sunitinib for the treatment of metastatic renal cell carcinoma. | Q37785348 | ||
| Bisphosphonate-related osteonecrosis of the jaws--a review. | Q38004731 | ||
| Osteonecrosis of the jaw - prevention and treatment strategies for oral health professionals | Q38124543 | ||
| Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents | Q38184580 | ||
| Antiangiogenesis therapy: an update after the first decade | Q38191586 | ||
| Antiresorptive drug-related osteonecrosis of the jaw. | Q38198175 | ||
| Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature. | Q38317759 | ||
| Drug induced osteonecrosis of the jaw. | Q38443072 | ||
| Jaw osteonecrosis associated with aflibercept, irinotecan and fluorouracil: attention to oral district | Q38583014 | ||
| Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology | Q38807483 | ||
| Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma. | Q39038321 | ||
| Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study. | Q40136437 | ||
| Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma. | Q40481345 | ||
| Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS). | Q41470599 | ||
| Bevacizumab-associated osteonecrosis of the jaw. | Q42536858 | ||
| Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study | Q42829926 | ||
| Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer | Q43111250 | ||
| Bevacizumab-related osteneocrosis of the jaw. | Q43194447 | ||
| Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic | Q43968160 | ||
| Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients | Q43973642 | ||
| Osteonecrosis of the mandible associated with bevacizumab therapy. | Q45060836 | ||
| Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2. | Q45721339 | ||
| Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome | Q46294584 | ||
| Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed. | Q46492569 | ||
| Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab | Q46535211 | ||
| Unusual bevacizumab-related complication of an oral infection | Q46744805 | ||
| Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort. | Q49990599 | ||
| Axitinib-related osteonecrosis of the jaw. | Q50054402 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis inhibitor | Q574834 |
| bisphosphonate-associated osteonecrosis of the jaw | Q866622 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 8071579 | |
| P577 | publication date | 2018-04-23 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature | |
| P478 | volume | 2018 |
| Q90567724 | From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights |
| Q90482843 | Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors |
| Q57800097 | Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review |
| Q92272586 | Review and update on drugs related to the development of osteonecrosis of the jaw |
Search more.